<DOC>
	<DOCNO>NCT00330551</DOCNO>
	<brief_summary>This study determine effectiveness oral risperidone versus long-acting injectable risperidone treat people first-episode schizophrenia .</brief_summary>
	<brief_title>Oral Versus Injectable Risperidone Treating First-Episode Schizophrenia</brief_title>
	<detailed_description>Schizophrenia severely disable brain disorder . People schizophrenia often experience hallucination , delusion , think disorder , movement disorder . Proper treatment first-episode schizophrenia may increase chance control disease progression long-term basis . People experience first episode schizophrenia responsive treatment chronic schizophrenia , also susceptible adverse treatment side effect . Atypical antipsychotic medication show produce few adverse side effect older `` typical '' antipsychotic . Risperidone type atypical antipsychotic medication use control symptoms schizophrenia . This study determine effectiveness oral risperidone versus long-acting injectable risperidone treat people first-episode schizophrenia . Participants open label study randomly assign receive either orally administer risperidone long-acting risperidone administer via injection . Participants assign oral risperidone receive medication dos determine optimal study psychiatrist . Participants assign long-acting risperidone receive injection risperidone every 2 week . Dosages begin 25 mg adjust necessary achieve optimal dosage . Following 2 3 month achieve outpatient risperidone dosage stabilization , randomize medication condition begin participant monitor 1 year . Study visit occur weekly throughout study . They include group therapy meeting focus everyday living skill ; family education schizophrenia ; assessment medication response ; individual meeting case manager counsel evaluation schizophrenia symptom .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>DSMIV diagnosis schizophrenia , schizoaffective disorder ( depressed type ) , schizophreniform disorder First major episode psychotic symptom occur within 2 year prior study entry Participant UCLA Center Neurocognition Emotion Schizophrenia Neurological disorder injury ( e.g. , encephalitis , epilepsy , traumatic brain injury ) Mental retardation ( e.g. , premorbid IQ le 70 ) Significant alcohol substance abuse within 6 month prior study entry Inability complete research measure English Any condition may make risperidone use medically inadvisable</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>November 2013</verification_date>
	<keyword>Schizoaffective Disorder , Depressed Type</keyword>
	<keyword>Schizophreniform Disorder</keyword>
	<keyword>First-episode Schizophrenia</keyword>
	<keyword>Injectable Risperidone</keyword>
</DOC>